Xenon Pharma CEO Buys $1.12M in Shares, Stock Rallies

Xenon Pharmaceuticals CEO Ian Mortimer bought 30,000 shares for $1.12 million, part of a larger insider buying spree totaling $1.68 million. The company is advancing its lead epilepsy drug, Azetukalner.